Medpace Holdings, Inc. (MEDP)

Medpace Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,963	1,886	1,460	1,142	925.93	860.97
Revenue Growth (YoY)	25.57%	29.17%	27.80%	23.38%	7.54%	22.19%
Cost of Revenue	1,413	1,361	1,028	814.22	647.2	615.27
Gross Profit	549.46	524.51	432.44	328.16	278.73	245.7
Selling, General & Admin	167.41	161.35	131.4	108.42	92.16	95.25
Other Operating Expenses	27.36	26.33	22.34	21.12	19.53	23.19
Operating Expenses	194.77	187.68	153.74	129.54	111.68	118.43
Operating Income	354.69	336.83	278.7	198.62	167.04	127.26
Interest Expense / Income	-4.49	0.49	2.91	0.11	-0.31	1.57
Other Expense / Income	-3.25	0.66	-7.07	-3.34	-1.18	0.86
Pretax Income	362.43	335.68	282.86	201.85	168.53	124.83
Income Tax	49.93	52.87	37.49	20	23.15	24.39
Net Income	312.51	282.81	245.37	181.85	145.38	100.44
Net Income Growth	21.62%	15.26%	34.93%	25.08%	44.74%	37.25%
Shares Outstanding (Basic)	31	31	32	36	36	36
Shares Outstanding (Diluted)	32	32	34	38	38	38
Shares Change	-0.48%	-5.43%	-10.68%	-0.03%	0.35%	1.80%
EPS (Basic)	10.17	9.20	7.57	5.06	4.07	2.79
EPS (Diluted)	9.81	8.88	7.28	4.81	3.84	2.67
EPS Growth	24.49%	21.98%	51.35%	25.26%	43.82%	35.53%
Free Cash Flow	473.34	396.73	351.17	235.06	227.34	183.96
Free Cash Flow Per Share	15.35	12.91	10.84	6.55	6.38	5.13
Gross Margin	27.99%	27.81%	29.62%	28.73%	30.10%	28.54%
Operating Margin	18.07%	17.86%	19.09%	17.39%	18.04%	14.78%
Profit Margin	15.92%	15.00%	16.81%	15.92%	15.70%	11.67%
Free Cash Flow Margin	24.12%	21.04%	24.05%	20.58%	24.55%	21.37%
Effective Tax Rate	13.78%	15.75%	13.25%	9.91%	13.74%	19.54%
EBITDA	405.89	382.14	326.12	239.36	201.68	159.54
EBITDA Margin	20.68%	20.26%	22.34%	20.95%	21.78%	18.53%
Depreciation & Amortization	47.95	45.97	40.36	37.41	33.45	33.14
EBIT	357.94	336.17	285.77	201.96	168.23	126.4
EBIT Margin	18.24%	17.83%	19.57%	17.68%	18.17%	14.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).